Free tool
FAERS Monitor: Cytotec
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019268 or its brand name (Cytotec, Misoprostol). Reports on generic versions are filed under their own applications.
Reports
9,774
Serious
6,754
69% of reports
Hospitalization
3,041
Death reported
746
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- haemorrhage1,260
- abortion incomplete1,159
- off label use924
- foetal exposure during pregnancy652
- pain542
- anaemia511
- pregnancy449
- nausea448
- drug ineffective442
- vomiting427
- maternal exposure during pregnancy420
- pyrexia408
- dizziness398
- muscle spasms352
- abdominal pain350
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 503 |
| 2005 | 419 |
| 2006 | 388 |
| 2007 | 347 |
| 2008 | 346 |
| 2009 | 385 |
| 2010 | 553 |
| 2011 | 611 |
| 2012 | 621 |
| 2013 | 409 |
| 2014 | 402 |
| 2015 | 376 |
| 2016 | 403 |
| 2017 | 415 |
| 2018 | 372 |
| 2019 | 451 |
| 2020 | 719 |
| 2021 | 498 |
| 2022 | 402 |
| 2023 | 329 |
| 2024 | 289 |
| 2025 | 307 |
| 2026 | 227 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,385 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| abortion incompleteSignal | 1,159 | 3544.7 | 3234.6 | 1,550,373 |
| pregnancySignal | 449 | 49.3 | 45.0 | 20,762 |
| haemorrhageSignal | 1,260 | 26.2 | 24.9 | 30,352 |
| foetal exposure during pregnancySignal | 652 | 17.4 | 16.1 | 10,015 |
| maternal exposure during pregnancySignal | 420 | 10.2 | 9.3 | 3,468 |
| anaemiaSignal | 511 | 5.8 | 5.3 | 2,027 |
| muscle spasmsSignal | 352 | 4.1 | 3.7 | 839 |
| abdominal painSignal | 350 | 3.2 | 2.9 | 545 |
| pyrexiaSignal | 408 | 2.5 | 2.3 | 385 |
| off label useSignal | 924 | 2.3 | 2.1 | 685 |
| vomiting | 427 | 2.0 | 1.8 | 203 |
| pain | 542 | 1.9 | 1.8 | 237 |
| dizziness | 398 | 1.7 | 1.6 | 121 |
| nausea | 448 | 1.2 | 1.1 | 18 |
| drug ineffective | 442 | 0.7 | 0.7 | 50 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.